Carlsmed reported revenue of $18.94M and net income of -$10.51M for the quarter ended Jun 2026, up 56.7% year over year. This income statement covers 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||
| Revenue | 6.08M | 6.59M | 9.41M | 10.19M | 12.08M | 13.07M | 15.16M | 16.12M | 18.94M |
| Cost of RevenueCost of Rev | 1.52M | 1.95M | 10.82M | 5.01M | 6.03M | 3.15M | 17.51M | 7.88M | 9.16M |
| Gross Profit | 4.56M | 4.80M | 7.02M | 7.64M | 8.87M | 9.93M | 11.61M | 12.43M | 14.54M |
| Operating items | |||||||||
| Research & DevelopmentR&D | 4.87M | 6.62M | 6.38M | 6.74M | 7.87M | 9.61M | 10.81M | 10.30M | 11.92M |
| Selling, General & AdministrativeSG&A | 2.01M | 1.92M | 2.33M | 3.47M | 3.34M | 4.91M | 4.85M | 6.23M | 7.62M |
| Other Operating ExpensesOther Opex | 4.00M | 4.04M | 3.02M | 3.15M | 4.16M | 4.45M | 5.26M | 5.18M | 6.04M |
| Operating ExpensesOpex | 10.88M | 12.57M | 11.72M | 13.36M | 15.37M | 18.96M | 20.93M | 21.70M | 25.58M |
| Operating IncomeOp. Inc | -6.32M | -7.78M | -4.70M | -5.72M | -6.50M | -9.04M | -9.32M | -9.28M | -11.04M |
| EBIT | -6.32M | -7.78M | -4.70M | -5.72M | -6.50M | -9.04M | -9.32M | -9.28M | -11.04M |
| Non-operating items | |||||||||
| Non Operating Interest Expenses | 0.33M | 0.40M | 12.14M | 4.91M | 5.17M | 0.38M | 23.21M | 7.90M | 10.31M |
| Interest & Investment IncomeInt & Inv Inc | 0.43M | 0.39M | 0.41M | 0.38M | 0.34M | 0.95M | 1.03M | 0.89M | 0.84M |
| Other Non Operating IncomeOther Non Op Inc. | 0.04M | -0.04M | -0.02M | -0.01M | -0.26M | 0.51M | 0.70M | 0.58M | 0.53M |
| Net income details | |||||||||
| EBT | -6.22M | -7.79M | -16.43M | -10.25M | -11.33M | -8.46M | -31.50M | -16.29M | -20.51M |
| Profit After TaxPAT | -6.28M | -7.81M | -4.72M | -5.73M | -6.77M | -8.53M | -8.61M | -8.70M | -10.51M |
| Income from Continuing OperationsIncome (Continuing) | -6.22M | -7.79M | -16.43M | -10.25M | -11.33M | -8.46M | -31.50M | -16.29M | -20.51M |
| Consolidated Net IncomeConsol Net Inc. | -6.22M | -7.79M | -16.43M | -10.25M | -11.33M | -8.46M | -31.50M | -16.29M | -20.51M |
| Income towards Parent CompanyParent Net Inc | -6.22M | -7.79M | -16.43M | -10.25M | -11.33M | -8.46M | -31.50M | -16.29M | -20.51M |
| Preferred Dividend PaymentsPref Dividends | 0.59M | 0.58M | |||||||
| Net Income towards Common StockholdersNet Income | -6.28M | -8.40M | -4.72M | -6.31M | -6.77M | -8.53M | -8.61M | -8.70M | -10.51M |
| Additional items | |||||||||
| EPS (Basic) | -1.55 | -2.06 | -1.16 | -1.47 | -1.47 | -0.40 | -0.61 | -0.32 | -0.39 |
| EPS (Diluted) | -1.55 | -2.06 | -1.16 | -1.47 | -1.47 | -0.40 | -0.61 | -0.32 | -0.39 |
| Shares Outstanding | 4.05M | 4.09M | 4.07M | 4.30M | 4.59M | 21.08M | 14.22M | 26.84M | 27.19M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 4.05M | 4.09M | 4.07M | 4.30M | 4.59M | 21.08M | 14.22M | 26.84M | 27.19M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 4.06M | 4.11M | 4.14M | 4.57M | 4.60M | 21.08M | 14.22M | 27.18M | 27.23M |
| EBITDA | -6.32M | -7.78M | -4.70M | -5.72M | -6.50M | -9.04M | -9.32M | -9.28M | -11.04M |
| Interest ExpensesInt Expense | 0.33M | 0.40M | 12.14M | 4.91M | 5.17M | 0.38M | 23.21M | 7.90M | 10.31M |